GATTAZZO, CRISTINA
 Distribuzione geografica
Continente #
NA - Nord America 2.187
EU - Europa 361
AS - Asia 348
OC - Oceania 3
AF - Africa 1
SA - Sud America 1
Totale 2.901
Nazione #
US - Stati Uniti d'America 2.187
CN - Cina 210
IT - Italia 118
SG - Singapore 100
DE - Germania 63
FI - Finlandia 62
GB - Regno Unito 42
SE - Svezia 37
VN - Vietnam 19
FR - Francia 14
IN - India 11
NL - Olanda 6
RU - Federazione Russa 6
IE - Irlanda 4
UA - Ucraina 4
AU - Australia 3
TR - Turchia 2
BG - Bulgaria 1
CH - Svizzera 1
CL - Cile 1
DK - Danimarca 1
ES - Italia 1
HK - Hong Kong 1
HU - Ungheria 1
JO - Giordania 1
JP - Giappone 1
KR - Corea 1
KW - Kuwait 1
LK - Sri Lanka 1
NG - Nigeria 1
Totale 2.901
Città #
Fairfield 295
Woodbridge 259
Chandler 246
Houston 197
Ashburn 163
Ann Arbor 148
Cambridge 123
Seattle 108
Wilmington 104
Singapore 75
Boardman 54
Beijing 43
Padova 41
Des Moines 37
Helsinki 37
Santa Clara 37
Princeton 32
Nanjing 30
Jacksonville 26
San Diego 25
Medford 22
Dong Ket 19
New York 15
Guangzhou 14
Falls Church 11
Jinan 9
Redwood City 9
Shenyang 9
Changsha 8
Milan 8
Cagliari 6
Dallas 6
Hebei 5
Nanchang 5
Roxbury 5
Shanghai 5
Chicago 4
Dublin 4
Hangzhou 4
Los Angeles 4
Pune 4
Amsterdam 3
Bournemouth 3
Formia 3
Haikou 3
Indiana 3
Jiaxing 3
Melbourne 3
Munich 3
Norwalk 3
Phoenix 3
Auburn Hills 2
Baotou 2
Bologna 2
Borås 2
Castelfranco di Sotto 2
Chengdu 2
Fuzhou 2
Hefei 2
Hounslow 2
Kunming 2
London 2
Luzzara 2
Marcon 2
Ningbo 2
Nürnberg 2
Paris 2
Parma 2
Piazzola Sul Brenta 2
Rome 2
Rosà 2
Taiyuan 2
Taizhou 2
Tianjin 2
Valsamoggia 2
Washington 2
Wuhan 2
Zhengzhou 2
Acton 1
Ahmedabad 1
Alghero 1
Amman 1
Ankara 1
Avenel 1
Bari 1
Bolzano 1
Budapest 1
Buffalo Junction 1
Copenhagen 1
Cormeilles-en-Parisis 1
Council Bluffs 1
Dambulla 1
Denver 1
Edinburgh 1
Falkenstein 1
Frankfurt am Main 1
Fulham 1
Hanover 1
Hong Kong 1
Islington 1
Totale 2.362
Nome #
3-(2,4-Dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione (SB216763), a Glycogen Synthase Kinase-3 Inhibitor, Displays Therapeutic Properties in a Mouse Model of Pulmonary Inflammation and Fibrosis 164
STAT3 mutation impacts biological and clinical features of T-LGL leukemia 160
Activating KIRs in Chronic Lymphoproliferative Disorder of NK Cells: Protection from Viruses and Disease Induction? 157
Cortactin, another player in the Lyn signaling pathway, is overexpressed and alternatively spliced in leukemic cells from patients with B-cell Chronic Lymphocytic Leukemia. 154
Profiling B cell chronic lymphocytic leukemia by reverse phase protein array: Focus on apoptotic proteins 148
Cortactin, a Lyn substrate, is a checkpoint molecule at the intersection of BCR and CXCR4 signalling pathway in chronic lymphocytic leukaemia cells. 138
Sarcoidosis is a Th1/Th17 multisystem disorder 136
Intrinsic and extrinsic mechanisms contribute to maintain the JAK/STAT pathway aberrantly activated in T-type large granular lymphocyte leukemia 134
Integrated CLL Scoring System, a New and Simple Index to Predict Time to Treatment and Overall Survival in Patients With Chronic Lymphocytic Leukemia 130
Leukaemic cells from chronic lymphocytic leukaemia patients undergo apoptosis following microtubule depolymerization and Lyn inhibition by nocodazole. 129
Cross-talk between chronic lymphocytic leukemia (CLL) tumor B cells and mesenchymal stromal cells (MSCs): implications for neoplastic cell survival 129
Lack of expression of inhibitory KIR3DL1 receptor in patients with natural killer cell-type lymphoproliferative disease of granular lymphocytes 118
Geldanamycin-induced Lyn dissociation from aberrant Hsp90-stabilized cytosolic complex is an early event in apoptotic mechanisms in B-chronic lymphocytic leukemia. 110
Detection of monoclonal T populations in patients with KIR-restricted chronic lymphoproliferative disorder of NK cells. 107
Lyn-mediated SHP-1 recruitment to CD5 contributes to resistance to apoptosis of B-cell chronic lymphocytic leukemia cells. 103
Lyn-mediated procaspase 8 dimerization blocks apoptotic signaling in B-cell chronic lymphocytic leukemia. 103
HS1, a Lyn Kinase Substrate, Is Abnormally Expressed in B-Chronic Lymphocytic Leukemia and Correlates with Response to Fludarabine-Based Regimen. 98
Intrinsic and Estrinsic Mechanism Contributes to Maintain the JAK/STAT Pathway Aberrantly Activated in T-Type Large Granular Lymphocyte Leukemia 95
CLL patients carrying 13q deletion show clinical heterogenity according to IGVH mutational status and CD38 expression 91
Increased Survival and Migration of CLL B-Cells in the Presence of Marrow Mesenchymal Stromal Cells: Novel Findings for Microenvironment-Targeted Therapies 85
S1P1 expression is controlled by the pro-oxidant activity of p66Shc and is impaired in B-CLL patients with unfavorable prognosis. 78
Role of inflammation in the development of lung fibrosis and in the pathogenesis of pulmunary hypertension 70
Phosphorylation of PP2A by Lyn is a key phenomenon in the cancer phenotype of B-CLL 67
B cells from Chronic Lymphocytic Leukemia undergo apoptosis following microtubule depolymerization by nocodazole 66
Are T-LGL Leukemia and NK-Chronic Lymphoproliferative Disorder really two distinct diseases? 58
Leukemic cell from B-CLL patients display heterogeneous response to the anti-apoptotic effect of mesenchymal stromal cells 54
CLL patients with low-risk cytogenetic abnormalities show clinical heterogeneity according to IGVH mutational status and CD38 expression 54
Totale 2.936
Categoria #
all - tutte 10.529
article - articoli 10.202
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.731


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020375 0 0 0 0 0 37 64 65 62 81 39 27
2020/2021359 32 27 13 23 18 21 12 40 46 50 46 31
2021/2022407 12 36 41 61 15 24 17 50 15 3 34 99
2022/2023464 77 56 14 79 55 58 5 28 59 5 25 3
2023/2024232 8 31 23 17 25 47 8 18 2 22 14 17
2024/2025257 0 51 47 53 70 36 0 0 0 0 0 0
Totale 2.936